Drugs to improve synaptic transmission
US7081474B2 · kind B2 · utility
0Cited by
2References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 22, 2004 |
| Grant date | Jul 25, 2006 |
| Priority date | — |
| Expiry date | Mar 22, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D313/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Peripherally administered Brefeldin A and its analogs and derivatives are used to enhance learning and reverse memory dysfunction through induced long term potentiation in hippocampal issues.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.